IGMS - RBC Capital upgrades IGM Biosciences to outperform
2024-02-09 17:10:51 ET
More on IGM Biosciences
- IGM Biosciences: A New Approach To Antibodies, But Not A Value Right Now
- IGM Biosciences to cut 22% of workforce, shut down blood cancer programs
- IGM Biosciences GAAP EPS of -$1.04 beats by $0.21, revenue of $0.51M misses by $0.34M
- Seeking Alpha’s Quant Rating on IGM Biosciences
- Historical earnings data for IGM Biosciences